GCE

(2~{S})-2-(3-azanylpropyl)-5-[2,5-bis(fluoranyl)phenyl]-~{N}-methoxy-~{N}-methyl-2-phenyl-1,3,4-thiadiazole-3-carboxamide

Find entries where: GCE

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	(2~{S})-2-(3-azanylpropyl)-5-[2,5-bis(fluoranyl)phenyl]-~{N}-methoxy-~{N}-methyl-2-phenyl-1,3,4-thiadiazole-3-carboxamide
Identifiers	(2~{S})-2-(3-azanylpropyl)-5-[2,5-bis(fluoranyl)phenyl]-~{N}-methoxy-~{N}-methyl-2-phenyl-1,3,4-thiadiazole-3-carboxamide
Formula	C₂₀ H₂₂ F₂ N₄ O₂ S
Molecular Weight	420.476
Type	NON-POLYMER
Isomeric SMILES	CN(C(=O)N1[C@](SC(=N1)c2cc(ccc2F)F)(CCCN)c3ccccc3)OC
InChI	InChI=1S/C20H22F2N4O2S/c1-25(28-2)19(27)26-20(11-6-12-23,14-7-4-3-5-8-14)29-18(24-26)16-13-15(21)9-10-17(16)22/h3-5,7-10,13H,6,11-12,23H2,1-2H3/t20-/m0/s1
InChIKey	LLXISKGBWFTGEI-FQEVSTJZSA-N

Chemical Details
Formal Charge	0
Atom Count	51
Chiral Atom Count	1
Bond Count	53
Aromatic Bond Count	12

Drug Info: DrugBank

DrugBank ID	DB06040
Name	Filanesib
Groups	investigational
Description	Filanesib is a potent Kinesin Spindle Protein (KSP) inhibitor that caused marked tumor regression in preclinical models of human solid tumors and human leukemias, often leading to durable responses.
Synonyms	Filanesib Hydrochloride Filanesib
Indication	Investigated for use/treatment in cancer/tumors (unspecified).
Categories	Antimitotic Agents Antineoplastic Agents Mitosis Modulators Sulfur Compounds Thiazoles
CAS number	885060-09-3

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Kinesin-like protein KIF11	MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEV...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682